DV
Dividend Vision

TXG — 10x Genomics Inc.

10x Genomics Inc. (TXG)

Total return is 6.3% over the past 6.9 years, 179.1 points behind SPY at 185.4%. Its deepest 1-year drawdown was 28.0%.

TXG is an equity fund that provides exposure to 10x Genomics Inc., a single-stock holding focused on genomics and life sciences technology. The fund does not distribute dividends and carries no yield profile, making it unsuitable for income-focused strategies. This holding appeals primarily to growth-oriented investors seeking direct exposure to the genomics sector rather than those prioritizing regular distributions.

TXG key facts

Asset type
Stock
Asset class
Equity
Inception date
09/12/2019
Distribution frequency
None
Last close
$56.09
Market cap
$7,308,031,488
Average volume
2014600.0
Beta
2.039
Payout ratio
0.0
Forward P/E
3333.3333
EPS
$-0.59